At a glance
ClinicalIndex Comparison RecordN/ACompleted· 167 enrolled
Drug / intervention
LASIK correction of hyperopic refractive errorsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided Lasik Correction of Hyperopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4 IR™ Excimer Laser System
In Brief
A clinical study evaluating LASIK correction of hyperopic refractive errors for Hyperopia. Completed, enrolled 167 participants across 9 sites.
Detailed Summary
Demonstrate that wavefront-guided LASIK using measurements from the iDesign System is safe and effective for the treatment of Hyperopia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 2012
Enrollment StartDec 2012
Primary CompletionOct 2016
TodayJul 2026
First PostedAug 30, 2012
Enrollment StartDec 31, 2012
Primary CompletionOct 31, 2016
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 13.8 years ago
Interventions
LASIK correction of hyperopic refractive errorsdevice
Surgeons will perform wavefront-guided LASIK based upon measurement obtained with the iDesign System